AAAAAA

   
Results: 1-8 |
Results: 8
Inhibition of angiogenesis-related endothelial activity by the experimental immunosuppressive agent leflunomide
Authors: Waldman, WJ Bickerstaff, A Gordillo, G Orosz, K Knight, DA Orosz, CG
Citation: Wj. Waldman et al., Inhibition of angiogenesis-related endothelial activity by the experimental immunosuppressive agent leflunomide, TRANSPLANT, 72(9), 2001, pp. 1578-1582
Inhibition of herpes simplex virus type 1 by the experimental immunosuppressive agent leflunomide
Authors: Knight, DA Hejmanowski, AQ Dierksheide, JE Williams, JW Chong, ASF Waldman, WJ
Citation: Da. Knight et al., Inhibition of herpes simplex virus type 1 by the experimental immunosuppressive agent leflunomide, TRANSPLANT, 71(1), 2001, pp. 170-174
Attenuation of cytomegalovirus-induced endothelial intercellular adhesion molecule-1 mRNA/protein expression and T lymphocyte adhesion by a 2 '-O-methoxyethyl antisense oligonucleotide
Authors: Knight, DA Briggs, BR Bennett, CF Harindranath, N Waldman, WJ Sedmak, DD
Citation: Da. Knight et al., Attenuation of cytomegalovirus-induced endothelial intercellular adhesion molecule-1 mRNA/protein expression and T lymphocyte adhesion by a 2 '-O-methoxyethyl antisense oligonucleotide, TRANSPLANT, 69(3), 2000, pp. 417-426
Inhibition of cytomegalovirus in vitro and in vivo by the experimental immunosuppressive agent leflunomide
Authors: Waldman, WJ Knight, DA Blinder, L Shen, JK Lurain, NS Miller, DM Sedmak, DD Williams, JW Chong, ASF
Citation: Wj. Waldman et al., Inhibition of cytomegalovirus in vitro and in vivo by the experimental immunosuppressive agent leflunomide, INTERVIROLO, 42(5-6), 1999, pp. 412-418
Trans vivo analysis of human delayed-type hypersensitivity reactivity
Authors: Carrodeguas, L Orosz, CG Waldman, WJ Sedmak, DD Adams, PW VanBuskirk, AM
Citation: L. Carrodeguas et al., Trans vivo analysis of human delayed-type hypersensitivity reactivity, HUMAN IMMUN, 60(8), 1999, pp. 640-651
Novel mechanism of inhibition of cytomegalovirus by the experimental immunosuppressive agent leflunomide
Authors: Waldman, WJ Knight, DA Lurain, NS Miller, DM Sedmak, DD Williams, JW Chong, ASF
Citation: Wj. Waldman et al., Novel mechanism of inhibition of cytomegalovirus by the experimental immunosuppressive agent leflunomide, TRANSPLANT, 68(6), 1999, pp. 814-825
Cytomegalovirus-mediated modulation of adhesion molecule expression by human arterial and microvascular endothelial cells
Authors: Knight, DA Waldman, WJ Sedmak, DD
Citation: Da. Knight et al., Cytomegalovirus-mediated modulation of adhesion molecule expression by human arterial and microvascular endothelial cells, TRANSPLANT, 68(11), 1999, pp. 1814-1818
Human cytomegalovirus inhibits IFN-alpha-stimulated antiviral and immunoregulatory responses by blocking multiple levels of IFN-alpha signal transduction
Authors: Miller, DM Zhang, YX Rahill, BM Waldman, WJ Sedmak, DD
Citation: Dm. Miller et al., Human cytomegalovirus inhibits IFN-alpha-stimulated antiviral and immunoregulatory responses by blocking multiple levels of IFN-alpha signal transduction, J IMMUNOL, 162(10), 1999, pp. 6107-6113
Risultati: 1-8 |